Achieve Life Sciences (ACHV) Asset Utilization Ratio (2011 - 2016)
Achieve Life Sciences (ACHV) posted Asset Utilization Ratio of 0.37 for Q1 2016, up 28.3% on a QoQ basis from 0.29 in Q4 2015, and up 12.89% year-over-year from 0.33 in Q2 2015.
Achieve Life Sciences (ACHV) Asset Utilization Ratio (2011 - 2016) Analysis & Trends
Achieve Life Sciences' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.37 for Q1 2016.
- Quarterly Asset Utilization Ratio rose 12.89% year-over-year to 0.37 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was 0.37 (up 12.89% YoY) and the FY2015 annual result came in at 0.32, down 34.5% from the prior year.
- Asset Utilization Ratio was 0.37 for Q1 2016 at Achieve Life Sciences, up from 0.29 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.71 in Q2 2014 and bottomed at 0.06 in Q2 2012.
- A 5-year average of 0.36 and a median of 0.33 in 2015 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2013 — Asset Utilization Ratio surged 596.14% — and 2015, when it plunged 59.05%.
- Achieve Life Sciences' Asset Utilization Ratio stood at 0.22 in 2012, then surged by 127.11% to 0.51 in 2013, then fell by 10.49% to 0.46 in 2014, then tumbled by 37.0% to 0.29 in 2015, then rose by 28.3% to 0.37 in 2016.
- Business Quant data shows ACHV's Asset Utilization Ratio at 0.37 in Q1 2016, 0.29 in Q4 2015, and 0.27 in Q3 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 0.37 |
| Dec 31, 2015 | 0.29 |
| Sep 30, 2015 | 0.27 |
| Jun 30, 2015 | 0.29 |
| Mar 31, 2015 | 0.33 |
| Dec 31, 2014 | 0.46 |
| Sep 30, 2014 | 0.54 |
| Jun 30, 2014 | 0.71 |
| Mar 31, 2014 | 0.69 |
| Dec 31, 2013 | 0.51 |
| Sep 30, 2013 | 0.47 |
| Jun 30, 2013 | 0.38 |
| Mar 31, 2013 | 0.30 |
| Dec 31, 2012 | 0.22 |
| Sep 30, 2012 | 0.11 |
| Jun 30, 2012 | 0.06 |
| Mar 31, 2012 | 0.06 |
| Dec 31, 2011 | 0.08 |
| Sep 30, 2011 | 0.09 |